| __timestamp | Johnson & Johnson | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 22746000000 | 179279000 |
| Thursday, January 1, 2015 | 21536000000 | 186359000 |
| Friday, January 1, 2016 | 21685000000 | 171785000 |
| Sunday, January 1, 2017 | 25354000000 | 208136000 |
| Monday, January 1, 2018 | 27091000000 | 198405000 |
| Tuesday, January 1, 2019 | 27556000000 | 224169000 |
| Wednesday, January 1, 2020 | 28427000000 | 245044000 |
| Friday, January 1, 2021 | 23402000000 | 252314000 |
| Saturday, January 1, 2022 | 24596000000 | 268225000 |
| Sunday, January 1, 2023 | 26553000000 | 304629000 |
| Monday, January 1, 2024 | 27471000000 | 324203000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial. This chart offers a fascinating glimpse into the cost of revenue trends for two industry titans: Johnson & Johnson and Taro Pharmaceutical Industries Ltd., from 2014 to 2023. Johnson & Johnson, a global leader, consistently reported a cost of revenue that dwarfs Taro's, reflecting its expansive operations. In 2023, Johnson & Johnson's cost of revenue was approximately 100 times that of Taro, highlighting the scale difference. However, Taro's cost of revenue has shown a steady increase, rising by about 70% from 2014 to 2023, indicating growth and expansion. Notably, data for Johnson & Johnson in 2024 is missing, suggesting a need for further investigation. This comparison underscores the diverse strategies and market positions of these companies, offering valuable insights for investors and industry analysts alike.
Comparing Cost of Revenue Efficiency: Eli Lilly and Company vs Johnson & Johnson
Johnson & Johnson vs Merck & Co., Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Johnson & Johnson vs Neurocrine Biosciences, Inc.
Cost of Revenue: Key Insights for Johnson & Johnson and Ionis Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Johnson & Johnson and Mesoblast Limited
Cost of Revenue Trends: Johnson & Johnson vs Viridian Therapeutics, Inc.
Johnson & Johnson vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Taro Pharmaceutical Industries Ltd.
Cost of Revenue Trends: Biogen Inc. vs Taro Pharmaceutical Industries Ltd.
Cost of Revenue Comparison: Walgreens Boots Alliance, Inc. vs Taro Pharmaceutical Industries Ltd.
Comparing Cost of Revenue Efficiency: Supernus Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.